These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34302692)

  • 21. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus.
    Pernis AB
    J Intern Med; 2009 Jun; 265(6):644-52. PubMed ID: 19493058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-210 expression in PBMCs from patients with systemic lupus erythematosus and rheumatoid arthritis.
    Huang Q; Chen SS; Li J; Tao SS; Wang M; Leng RX; Pan HF; Ye DQ
    Ir J Med Sci; 2018 Feb; 187(1):243-249. PubMed ID: 28560518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell receptor β repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis.
    Liu X; Zhang W; Zhao M; Fu L; Liu L; Wu J; Luo S; Wang L; Wang Z; Lin L; Liu Y; Wang S; Yang Y; Luo L; Jiang J; Wang X; Tan Y; Li T; Zhu B; Zhao Y; Gao X; Wan Z; Huang C; Fang M; Li Q; Peng H; Liao X; Chen J; Li F; Ling G; Zhao H; Luo H; Xiang Z; Liao J; Liu Y; Yin H; Long H; Wu H; Yang H; Wang J; Lu Q
    Ann Rheum Dis; 2019 Aug; 78(8):1070-1078. PubMed ID: 31101603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive review of genetic association studies and meta-analysis on miRNA polymorphisms and rheumatoid arthritis and systemic lupus erythematosus susceptibility.
    Fu L; Jin L; Yan L; Shi J; Wang H; Zhou B; Wu X
    Hum Immunol; 2016 Jan; 77(1):1-6. PubMed ID: 25218914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gaseous mediators in resolution of inflammation.
    Wallace JL; Ianaro A; Flannigan KL; Cirino G
    Semin Immunol; 2015 May; 27(3):227-33. PubMed ID: 26095908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis.
    Santos LL; Morand EF
    Clin Chim Acta; 2009 Jan; 399(1-2):1-7. PubMed ID: 18838066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.
    Zink A; Fischer-Betz R; Thiele K; Listing J; Huscher D; Gromnica-Ihle E; Specker C; Schneider M;
    Lupus; 2004; 13(7):529-36. PubMed ID: 15352425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel slow-releasing hydrogen sulfide donor, FW1256, exerts anti-inflammatory effects in mouse macrophages and in vivo.
    Huang CW; Feng W; Peh MT; Peh K; Dymock BW; Moore PK
    Pharmacol Res; 2016 Nov; 113(Pt A):533-546. PubMed ID: 27687956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus.
    Márquez A; Vidal-Bralo L; Rodríguez-Rodríguez L; González-Gay MA; Balsa A; González-Álvaro I; Carreira P; Ortego-Centeno N; Ayala-Gutiérrez MM; García-Hernández FJ; González-Escribano MF; Sabio JM; Tolosa C; Suárez A; González A; Padyukov L; Worthington J; Vyse T; Alarcón-Riquelme ME; Martín J
    Ann Rheum Dis; 2017 Jan; 76(1):286-294. PubMed ID: 27193031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.
    Leonard D; Svenungsson E; Dahlqvist J; Alexsson A; Ärlestig L; Taylor KE; Sandling JK; Bengtsson C; Frodlund M; Jönsen A; Eketjäll S; Jensen-Urstad K; Gunnarsson I; Sjöwall C; Bengtsson AA; Eloranta ML; Syvänen AC; Rantapää-Dahlqvist S; Criswell LA; Rönnblom L
    Ann Rheum Dis; 2018 Jul; 77(7):1063-1069. PubMed ID: 29514802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular hydrogen: new antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases.
    Ishibashi T
    Curr Pharm Des; 2013; 19(35):6375-81. PubMed ID: 23859555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of the PD-1 protein in pathogenesis of autoimmune diseases, with particular consideration of rheumatoid arthritis and systemic lupus erythematosus].
    Siwiec A; Majdan M
    Postepy Hig Med Dosw (Online); 2015 Apr; 69():534-42. PubMed ID: 25983292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTPN22 polymorphisms, but not R620W, were associated with the genetic susceptibility of systemic lupus erythematosus and rheumatoid arthritis in a Chinese Han population.
    Tang L; Wang Y; Zheng S; Bao M; Zhang Q; Li J
    Hum Immunol; 2016 Aug; 77(8):692-698. PubMed ID: 27166176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role Ofhydrogen Sulfide on Inflammatory Immune Disorders in Cardiovascular Diseases].
    Pan LL; Liu XH; Zhu YZ
    Sheng Li Ke Xue Jin Zhan; 2017 Feb; 48(1):30-6. PubMed ID: 29927218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus.
    Ostensen M
    Ann N Y Acad Sci; 1999 Jun; 876():131-43; discussion 144. PubMed ID: 10415601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study.
    Tsuda S; Sameshima A; Sekine M; Kawaguchi H; Fujita D; Makino S; Morinobu A; Murakawa Y; Matsui K; Sugiyama T; Watanabe M; Suzuki Y; Nagahori M; Murashima A; Atsumi T; Oku K; Mitsuda N; Takei S; Miyamae T; Takahashi N; Nakajima K; Saito S;
    Mod Rheumatol; 2020 Sep; 30(5):852-861. PubMed ID: 31483178
    [No Abstract]   [Full Text] [Related]  

  • 37. Methotrexate use in miscellaneous inflammatory diseases.
    Wilke WS
    Rheum Dis Clin North Am; 1997 Nov; 23(4):855-82. PubMed ID: 9361159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus.
    Cohen S; Clowse M; Pardo P; Bhattacharya I; Menon S; Gourley I; Diehl A
    Clin Ther; 2016 Jun; 38(6):1417-1434.e2. PubMed ID: 27112532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydrogen sulfide inhibits abnormal proliferation of lymphocytes via AKT/GSK3β signal pathway in systemic lupus erythematosus patients.
    Han Y; Zeng F; Tan G; Yang C; Tang H; Luo Y; Feng J; Xiong H; Guo Q
    Cell Physiol Biochem; 2013; 31(6):795-804. PubMed ID: 23735868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-17A haplotype confers susceptibility to systemic lupus erythematosus but not to rheumatoid arthritis in Mexican patients.
    Montúfar-Robles I; Barbosa-Cobos RE; Alemán-Ávila I; Ramírez-Bello J
    Int J Rheum Dis; 2019 Mar; 22(3):473-479. PubMed ID: 30398030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.